（オンライン開催）第140回HGPIセミナー「COPDの疾病負担軽減を目指した早期発見の重要性：臨床現場と政策をつなぐ呼吸器医療の展望」

日本医療政策機構（HGPI）では、医療政策のオピニオンリーダーやイノベーターを招き、さまざまな医療政策のテーマに関するセミナーを開催しています。

本セミナーでは、日本の医療環境や生活習慣の特徴上、潜在患者が多いとされるCOPDに焦点を当て、奈良県立医科大学の室繁郎氏をお招きし、国民・患者に求められる受療行動や自治体・国で取り組むべき政策上の課題まで幅広くご講演いただきます。

臨床現場と研究分野での豊富な経験を基に、科学的な知見と政策的観点の両面から、呼吸器内科が保健医療システムにおいて果たすべき役割と可能性について具体的にお話しいただきます。COPDを切り口に、保健医療システム全体の課題と可能性を再認識し、個人レベルから政策レベルまでの改善アクションにつなげていくきっかけとなることを期待しています。

■ 登壇者プロフィール

室 繁郎（奈良県立医科大学呼吸器内科学講座教授／奈良県立医科大学附属病院副病院長（兼務））
1989年京都大学医学部卒業後、田附興風会北野病院勤務を経て、1998年京都大学大学院博士課程修了（医学博士）。マギル大学ミーキンス・クリスティー研究所研究員、京都大学講師・准教授を経て、2018年より現職。日本呼吸器学会常務理事・保険委員会委員長を務めるほか、同学会の「COPD診断と治療のためのガイドライン」第5～7版では責任編集委員・副委員長を歴任し、「喘息とCOPDのオーバーラップ診断と治療の手引き」第2版（2024年発行）では委員長。同学会のCOPD死亡率の低減を目指すプロジェクト「木洩れ陽2032」の活動にも積極的に関わっている。第42回ベルツ賞1等賞（2005年）、日本呼吸器学会熊谷賞（2014年）受賞。

>> 詳細はこちら

(Webinar) The 140th HGPI Seminar “Early Detection to Reduce COPD Disease Burden: Connecting Clinical Frontiers with Health Policy”
*Please note that this seminar is available in Japanese only.

Health and Global Policy Institute (HGPI) holds seminars with opinion leaders and innovators on a wide-range of domestic and international topics related to health policy.

In this HGPI Seminar, we will focus on COPD, a disease with a high number of potential patients due to characteristics of Japan’s healthcare environment and lifestyle. We are honored to welcome Dr. Shigeo Muro from Nara Medical University, who will deliver a comprehensive lecture covering a broad range of topics—from healthcare-seeking behaviors expected of citizens and patients to policy challenges that should be addressed at the municipal and national levels.

Drawing on his extensive experience in both clinical practice and research, Dr. Muro will provide concrete insights into the role and potential of respiratory medicine within the healthcare system from both scientific and policy perspectives. Using COPD as a lens, we hope this seminar will serve as an opportunity to reaffirm the challenges and possibilities of the overall healthcare system and to inspire actions for improvement ranging from the individual to the policy level.

■Speaker's Profile

Dr. Shigeo Muro (Professor, Department of Respiratory Medicine, Nara Medical University / Vice Director, Nara Medical University Hospital)
Professor Muro graduated from Kyoto University Faculty of Medicine in 1989 and worked at Tazuke Kofukai Kitano Hospital before completing his doctoral program at Kyoto University Graduate School in 1998 (Ph.D. in Medicine). After serving as a research fellow at McGill University Meakins-Christie Laboratories and as lecturer and associate professor at Kyoto University, he assumed his current position in 2018. He serves as Executive Director and Chair of the Insurance Committee of the Japanese Respiratory Society. He served as Chief Editor and Vice-Chair for the 5th through 7th editions of the society’s ‘Guidelines for the Diagnosis and Treatment of COPD’ and as Chair for the 2nd edition of ‘Guidelines for the Diagnosis and Treatment of Asthma and COPD Overlap’ (published in 2024). He is also actively involved in ‘Komorebi 2032,’ the society’s project aimed at reducing COPD mortality rates. He received the 1st Prize of the 42nd Baelz Award (2005) and the Japanese Respiratory Society Kumagai Award (2014).

>> For more information, click here